Testicular Tumors: 40 Years’ Experience

Culp, David A.; Boatman, D.L.; Wilson, V.B.

doi:10.1016/s0022-5347(17)60277-5

Cited by 25 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In der Regel metastasieren Teratome frühzeitig in die regionären Lymphknoten. Tumoren mit chorionkarzinomatösen Anteilen, wie im hier geschilderten Fall, breiten sich allerdings sehr rasch auch hämatogen aus und gelten als bösartigste Variante der Teratome (2,5).…”

Section: Diskussionunclassified

Jejunale Blutung als Erstsymptom eines metastasierten testikulären Chorionkarzinoms

Vorreuther¹,

Sander²,

Raab³

et al. 1990

Aktuel Urol

View full text Add to dashboard Cite

Section: Diskussionunclassified

Jejunale Blutung als Erstsymptom eines metastasierten testikulären Chorionkarzinoms

Vorreuther¹,

Sander²,

Raab³

et al. 1990

Aktuel Urol

View full text Add to dashboard Cite

Megavoltage irradiation for pure testicular seminoma: Results and patterns of failure

Dosoretz

Shipley

Blitzer

et al. 1981

Cancer

View full text Add to dashboard Cite

The survival, patterns, and mechanisms of failure in 171 patients with pure testicular seminoma treated with megavoltage irradiation from 1950 to 1976 were analyzed. The survival of the entire group was 93% at five and ten years post-irradiation. Survival at five years was significantly less for Stages III and IV (45%) when compared with Stages I and II (95%, P less than 0.001). Extranodal relapses were more common in early stages, and abdominal recurrences occurred in more advanced stages. Salvage treatment, management of HCG-producing seminomas, and second testicular seminomas are analyzed. The need for aggressive and appropriate radiation technique is emphasized.

show abstract

The Management of Testicular Seminomas, 1979

Caldwell

Kademian

Frias

et al. 1980

Cancer

View full text Add to dashboard Cite

The reported results from throughout the world of modern treatment of testicular seminoma are reviewed for the various clinical stages of disease. The three-year survival rate for 1,346 patients with Stage 1 and 2 disease is 91%. Since the review reveals considerable differences in staging methods, a clinically useful staging system is proposed. Treatment methods are described and discussed. Recommendations are made assuming that patients so treated are clinically evaluated for extent of disease before treatment with currently available techniques, including lymphangiography, CT scanning, perhaps ultrasonography, and serum marker determinations. Although the role of cytoreductive surgery in patients with seminoma, even bulky seminoma, now is limited, occasionally when laparotomy is done, debulking may also be helpful. Effective combination chemotherapy regimens have not been identified. The 28% three-year survival rate of patients with Stage 3 disease establishes the real need to identify such therapy. Finally, anaplastic seminoma is considered; a recent review by Percarpio indicates that this subtype perhaps is not unlike classical seminoma as far as stage distribution and prognosis is concerned.

show abstract

Testicular Tumors: 40 Years’ Experience

Cited by 25 publications

References 4 publications

Jejunale Blutung als Erstsymptom eines metastasierten testikulären Chorionkarzinoms

Jejunale Blutung als Erstsymptom eines metastasierten testikulären Chorionkarzinoms

Megavoltage irradiation for pure testicular seminoma: Results and patterns of failure

The Management of Testicular Seminomas, 1979

Contact Info

Product

Resources

About